Drugs / Lactobacillus gasseri BGP345A
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05133076 Comparator | Jan 2022 → Dec 2024 | opioid-induced constipation | BioGaia Pharma AB | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lactobacillus gasseri BGP345A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05133076 ↗ |
| Route | Oral | “Active and placebo capsules for oral use” NCT05133076 ↗ |